Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00693329 · ClinicalTrials.gov registry record
Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy
A clinical trial of Cardiovascular Surgery With Coronary Angiography, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 260
- Enrollment target
- 3
- Study locations
NCT00693329: Completed study of Cardiovascular Surgery With Coronary Angiography, sponsored by Abbott RDx Cardiometabolic.
NCT00693329 is a study of Cardiovascular Surgery With Coronary Angiography that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 260 participants. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00693329, a study of Cardiovascular Surgery With Coronary Angiography, has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multi-center clinical study designed to assess the performance of the Triage NGAL test as an aid in the early risk assessment for contrast-induced nephropathy (CIN). Approximately 260 adults at risk for CIN undergoing intra-arterial angiography involving administration of iodinated contrast agent(s) will be enrolled.
Conditions Studied
Study Locations (3)
Michigan
- Cardiac and Vascular Research Center of Northern Michigan - Petoskey
- Providence Hospital - Providence
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-12 |
What the finished NCT00693329 record still lists
NCT00693329 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Cardiovascular Surgery With Coronary Angiography appearing as the primary indexed condition, and to 0 interventions.
NCT00693329 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00693329 about?
NCT00693329 is a clinical study titled "Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy". This is a multi-center clinical study designed to assess the performance of the Triage NGAL test as an aid in the early risk assessment for contrast-induced nephropathy (CIN). Approximately 260 adults at risk for CIN undergoing intra-arterial angiography involving administration of iodinated contras...
What is the current status of trial NCT00693329?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2008-03. Estimated completion is 2009-12.
What conditions does trial NCT00693329 study?
This clinical trial studies the following conditions: Cardiovascular Surgery With Coronary Angiography.
Who is sponsoring clinical trial NCT00693329?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00693329 being conducted?
This trial has 3 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia